Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-02-25 @ 6:43 PM
Study NCT ID:
NCT00546156
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2007-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
Sponsor:
Ian E. Krop, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
07-130
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None